Search by Drug Name or NDC
NDC 68462-0500-33 zolmiptriptan 5 mg/1 Details
zolmiptriptan 5 mg/1
zolmiptriptan is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is ZOLMITRIPTAN.
MedlinePlus Drug Summary
Zolmitriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Zolmitriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Zolmitriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 68462-0500-33Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Zolmitriptan
Product Information
| NDC | 68462-0500 |
|---|---|
| Product ID | 68462-500_6ee6f1b7-e5f0-4273-897c-b771a8f1c828 |
| Associated GPIs | 67406080007230 |
| GCN Sequence Number | 048643 |
| GCN Sequence Number Description | zolmitriptan TAB RAPDIS 5 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 14324 |
| HICL Sequence Number | 012958 |
| HICL Sequence Number Description | ZOLMITRIPTAN |
| Brand/Generic | Generic |
| Proprietary Name | zolmiptriptan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | zolmitriptan |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ZOLMITRIPTAN |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202560 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0500-33 (68462050033)
| NDC Package Code | 68462-500-33 |
|---|---|
| Billing NDC | 68462050033 |
| Package | 1 BLISTER PACK in 1 CARTON (68462-500-33) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Marketing Start Date | 2013-05-14 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 3.98241 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ZOLMITRIPTAN 5 MG ODT |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |